Captrust Financial Advisors Nektar Therapeutics Transaction History

Captrust Financial Advisors

  • $30 Billion
  • Q1 2024

A detailed history of Captrust Financial Advisors transactions in Nektar Therapeutics stock. As of the latest transaction made, Captrust Financial Advisors holds 12,000 shares of NKTR stock, worth $14,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,000
Previous 12,024 0.2%
Holding current value
$14,880
Previous $6,000 83.33%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.49 - $0.96 $11 - $23
-24 Reduced 0.2%
12,000 $11,000
Q4 2023

Feb 14, 2024
SELL
$0.42 - $0.57 $2,578 - $3,499
-6,139 Reduced 33.8%
12,024 $6,000
Q3 2023

Nov 14, 2023
BUY
$0.51 - $1.05 $1,824 - $3,756
3,578 Added 24.53%
18,163 $10,000
Q2 2023

Aug 14, 2023
SELL
$0.53 - $1.03 $2,441 - $4,744
-4,606 Reduced 24.0%
14,585 $8,000
Q1 2023

May 15, 2023
BUY
$0.64 - $3.15 $12,282 - $60,451
19,191 New
19,191 $13,000
Q3 2022

Nov 16, 2022
BUY
$3.04 - $5.14 $60,064 - $101,556
19,758 Added 600.36%
23,049 $74,000
Q2 2022

Aug 16, 2022
BUY
$3.17 - $6.17 $1,157 - $2,252
365 Added 12.47%
3,291 $13,000
Q1 2022

May 16, 2022
BUY
$4.16 - $13.72 $4,147 - $13,678
997 Added 51.68%
2,926 $16,000
Q4 2021

Feb 14, 2022
BUY
$10.83 - $18.41 $2,815 - $4,786
260 Added 15.58%
1,929 $26,000
Q3 2021

Nov 16, 2021
BUY
$13.07 - $18.84 $731 - $1,055
56 Added 3.47%
1,669 $30,000
Q2 2021

Aug 16, 2021
SELL
$16.52 - $20.4 $198 - $244
-12 Reduced 0.74%
1,613 $28,000
Q1 2021

May 17, 2021
BUY
$16.56 - $25.46 $21,114 - $32,461
1,275 Added 364.29%
1,625 $32,000
Q4 2020

Feb 16, 2021
BUY
$15.77 - $19.03 $946 - $1,141
60 Added 20.69%
350 $6,000
Q3 2020

Nov 17, 2020
BUY
$16.59 - $24.79 $4,811 - $7,189
290 New
290 $5,000
Q3 2019

Nov 14, 2019
SELL
$16.91 - $36.27 $1,014 - $2,176
-60 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$31.0 - $36.3 $1,860 - $2,178
60 New
60 $2,000

Others Institutions Holding NKTR

# of Institutions
128
Shares Held
111M
Call Options Held
150K
Put Options Held
4K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $232M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email